Abbott Laboratories (ABT)

ABT on New York Consolidated

36.84USD
1 Aug 2013
Price Change (% chg)

$0.21 (+0.57%)
Prev Close
$36.63
Open
$36.89
Day's High
$37.07
Day's Low
$36.68
Volume
7,468,830
Avg. Vol
7,303,720
52-wk High
$72.47
52-wk Low
$31.64

ABT

Chart for ABT

About

Abbott Laboratories (Abbott), is engaged in the discovery, development, manufacture, and sale of a portfolio of science-based health care products. Abbott operates in four business segments: diagnostics, medical devices, nutritionals and generic pharmaceuticals. Geographically, 30% of its revenue is generated in the United... (more)

Overall

Beta: 0.36
Market Cap (Mil.): $57,101.21
Shares Outstanding (Mil.): 1,558.86
Dividend: 0.14
Yield (%): 1.53

Financials

  ABT Industry Sector
P/E (TTM): 69.17 37.93 37.76
EPS (TTM): 0.53 -- --
ROI: -- 19.48 18.76
ROE: -- 20.17 19.59
Search Stocks

Abbott profit beats forecast, nutritional products strong

- Abbott Laboratories reported better-than-expected second-quarter earnings on Wednesday as strong demand for nutritional products offset lower sales of medical devices and generic prescription drugs.

17 Jul 2013

UPDATE 3-Abbott profit beats forecast, nutritional products strong

* Adj earnings 46 cents/share vs Wall Street view 44 cents

17 Jul 2013

Abbott profit beats forecast, nutrition brands offset weak device sales

July 17 - Abbott Laboratories reported better-than-expected quarterly earnings on Wednesday as strong demand for its nutritional products offset lower sales of medical devices and generic prescription drugs.

17 Jul 2013

Abbott to cut milk powder prices in China after probe

SHANGHAI, July 12 - Abbott Laboratories is cutting prices of its instant products in China by up to 12 percent, the company said, joining other foreign firms in responding to Beijing's probe into possible price-fixing by milk powder makers.

12 Jul 2013

UPDATE 2-China probes infant milk firms for antitrust violations

* Danone, Nestle, Mead Johnson, Abbott cooperating with investigation

02 Jul 2013

Abbvie says Chief Scientific Officer John Leonard to retire

- AbbVie Inc's chief scientific officer will be retiring in the next few months and will be involved in the process of naming a successor, the pharmaceutical company said in a regulatory filing on Friday.

10 May 2013

Abbvie says Chief Scientific Officer John Leonard to retire

May 10 - AbbVie Inc's chief scientific officer will be retiring in the next few months and will be involved in the process of naming a successor, the pharmaceutical company said in a regulatory filing on Friday.

10 May 2013

UPDATE 1-Russia rejects Abbott Laboratories' plan to buy Petrovax

MOSCOW, April 19 - Russia's government commission on foreign investment has turned down U.S. group Abbott Laboratories' request to buy Russian vaccine maker Petrovax, the head of Russia's competition regulator said on Friday.

19 Apr 2013

Russia rejects Abbott Laboratories' plan to buy Petrovax

MOSCOW - Russia's government commission on foreign investment has rejected U.S. Abbott Laboratories' plan to buy Russian pharmaceutical producer Petrovax, the head of the Russian antitrust regulator said on Friday.

19 Apr 2013

Russia rejects Abbott Laboratories' plan to buy Petrovax

MOSCOW, April 19 - Russia's government commission on foreign investment has rejected U.S. Abbott Laboratories' plan to buy Russian pharmaceutical producer Petrovax, the head of the Russian antitrust regulator said on Friday.

19 Apr 2013

Competitors

  Price Change
Johnson & Johnson (JNJ.N) $93.77 +0.27
Pfizer Inc. (PFE.N) $29.11 -0.12
GlaxoSmithKline plc (GSK.L) 1,712.50p +28.50
Novartis AG (NOVN.VX) CHF66.60 +0.35
Eli Lilly & Co. (LLY.N) $53.50 +0.39
Merck & Co., Inc. (MRK.N) $48.58 +0.41
AstraZeneca plc (AZN.L) 3,334.00p -1.00
Sanofi SA (SASY.PA) €76.85 -3.32
Amgen, Inc. (AMGN.OQ) $109.45 +1.16
Angiotech Pharmaceuticals, Inc. (USA) (ANPMF.PK) $25.00 +8.25

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: Wright Reports
$472.00
Provider: Stock Traders Daily
$58.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks